Profilo
Graham Parry worked as Biology Director at Attenuon, LLC and as Principal at Motility, Inc. He also worked as Vice President-Technical Operations at True North Therapeutics, Inc. from 2014 to 2017.
Parry received his undergraduate degree from Brunel University and his doctorate degree from the University of London.
Precedenti posizioni note di Graham Parry
| Società | Posizione | Fine |
|---|---|---|
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
| Motility, Inc. | Corporate Officer/Principal | - |
| Attenuon, LLC | Corporate Officer/Principal | - |
Formazione di Graham Parry
| Brunel University | Undergraduate Degree |
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
| Attenuon, LLC | |
| Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Graham Parry
